GERALD TRAVIS: Open Payments
NPI 1487667150 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 22 payments from 8 companies in 2025. Trend: 2023 $430 · 2024 $389 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $181 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Lundbeck LLC | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Alkermes, Inc. | 1 | $28 |
| Corium, LLC | 1 | $25 |
| Neos Therapeutics, LP | 1 | $14 |
Products named: VRAYLAR, REXULTI, TRINTELLIX, CAPLYTA, ARISTADA, Azstarys, Adzenys XR-ODT.
Industry payments across NC — which companies pay providers there.
